Press Release: Lazar Partners : AGTC Announces Sue Washer, CEO, Elected to Biotechnology Innovation Organization's Board of Directors

GAINESVILLE, Fla., and CAMBRIDGE, Mass., Feb. 14, 2018 -- Applied Genetic Technologies Corporation (NASDAQ:AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, today announced the election of Sue Washer, President and Chief Executive Officer, to the Biotechnology Innovation Organization (BIO)’s Board of Directors.